Our Leadership Team
Joe Blanchard, M.B.A
President & Chief Executive Officer
Learn more about Mr. Blanchard
Michel Baudry, Ph.D.
Founder & Scientific Advisor
Learn more about Dr. Baudry
Dr. Baudry is an internationally known neuroscientist with over 400 publications and is one of the 100 most cited neuroscientists in the world. He is a professor at Western University of Health Sciences and former professor of biological sciences, neurology and biomedical engineering at University of Southern California in Los Angeles. Dr. Baudry graduated from Ecole Polytechnique in Paris and earned a PhD in biochemistry at University of Paris VII under the direction of professors J.C. Schwartz and J.P. Changeux, two of France’s most distinguished neurobiologists.
Michael Palfreyman, DSc., Ph.D.
SVP Drug Development
Learn more about Dr. Palfreyman
Dr. Palfreyman is an internationally recognized leader in neurological drug development with a successful scientific and business career spanning 35 years. He brings to NeurAegis a distinguished track record of successful drug development and considerable expertise in CNS pharmacology, pharmacogenomics and rational drug design. Dr. Palfreyman’s broad perspective on drug development derives from his experience as Chief Scientific Officer for Amorsa Therapeutics and President and CSO of Psychiatric Genomics; Senior Scientific Advisor to EnVivo Pharmaceuticals and Vitruvean; co-founder of NOVACE; Senior VP for Research and Development at Anadys (formerly Scriptgen); as well as senior executive and scientific leadership roles at Marion Merrell Dow (Sanofi-Aventis) and Beecham (GlaxoSmithKline). In these roles, he successfully developed and demonstrated clinical efficacy of several candidates across multiple therapeutic areas. Dr. Palfreyman holds Ph.D. and D.Sc. degrees and is a member of the Royal Pharmaceutical Society. He continues to be an active scientific contributor with more than 150 publications and 35 issued patents.
Imad Najm, M.D.
Learn more about Dr. Najm
Imad Michel Najm, MD, is Director of Cleveland Clinic’s Epilepsy Center at the Cleveland Clinic Neurological Institute. Dr. Najm received his medical doctor degree from Saint Joseph University in Beirut, Lebanon, in 1988. Dr. Najm completed his residency in adult neurology at Cleveland Clinic in 1996, and a fellowship in clinical neurophysiology and epilepsy at Cleveland Clinic in 1997. Dr. Najm received his board certification in adult neurology from the American Board of Psychiatry and Neurology in 1998, with an added qualification in clinical neurophysiology in 1999. Between 2000 and 2003, Dr. Najm served as the director of the Epilepsy and Clinical Neurophysiology Fellowship Program at Cleveland Clinic. In 2003, he became the Head of the Section of Adult Epilepsy within the Department of Neurology at Cleveland Clinic, and in 2006, he assumed his current position as the Director of the Cleveland Clinic Epilepsy Center. Dr. Najm has more than 22 years of experience in clinical and basic mechanisms of epilepsy. This includes conducting numerous research projects dedicated to exploring the topic of mechanisms of epilepsy and malformations of cortical dysplasia.